How about "never buy a biotech trading for a quarter" on the OTC markets? Add that to "never buy an IPO unless it's a daytrade" - the office messaging app Slack (WORK) IPO'd last Thursday, stock went up almost twice as high from it's actual value provided by investment banks to ridiculous P/S levels (IIRC 35x) - and insiders have twice as many shares in options and RSUs than the current shares out (~193M) - fully diluted share count is 505M! Selling AMRN stock to purchase NWBO is a fool's game.
News 
Market Data 
Discover 
